VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CRMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CRMDCorMedix Inc.
$7.77$610M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRMDQuarterly Financials

CorMedix Inc. (CRMD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

CorMedix Inc. (CRMD) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CRMD Income Statement

Quarterly statement

CRMD Income Statement

CorMedix Inc. (CRMD) annual income statement — 18-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue101.93M127.43M128.62M104.28M39.74M39.08M31.21M11.46M806.12K0000029.7K6.82K21.25K7.64K56.4K38.09K
Revenue Growth %156.52%226.05%312.1%810.22%4829.4%------100%-100%-100%-100%-47.33%-82.1%159.47%-91.35%1.23%-59.05%
Cost of Goods Sold24.8M22.3M21.31M11.19M1.86M1.6M1.18M686.6K509.84K818.54K53.51K51.86K50.75K49.45K4061.47K3321.53K48.01K25.17K
COGS % of Revenue24.34%17.5%16.57%10.74%4.69%4.09%3.77%5.99%63.25%-----1.37%21.55%1.56%20%85.12%66.07%
Gross Profit77.13M105.12M107.31M93.08M37.87M37.48M30.03M10.77M296.28K-818.54K-53.51K-51.86K-50.75K-49.45K29.3K5.35K20.92K6.11K8.39K12.92K
Gross Margin %75.66%82.5%83.43%89.26%95.31%95.91%96.23%94.01%36.75%-----98.63%78.45%98.44%80%14.88%33.93%
Gross Profit Growth %103.64%180.44%257.28%764.3%12683.29%4679.49%56231.68%20865.72%683.83%-1555.45%-282.64%-1069.75%-342.57%-909.38%249.18%-58.61%435.54%-77.31%651.97%-1.41%
Operating Expenses34.22M41.46M48.18M41.73M18.33M17.36M17.1M14.06M15.6M15.89M15.62M10.42M11.75M10.97M8.42M6.97M8.26M7.04M7.79M8.58M
OpEx % of Revenue33.57%32.54%37.46%40.02%46.13%44.42%54.78%122.7%1934.84%-----28343.29%102204.52%38871.53%92174.83%13809.8%22521.11%
Selling, General & Admin27.53M34.25M39.58M36.64M15.89M14.17M15.37M13.33M14.95M15.05M13.33M7.8M7.01M7.56M5.58M4.63M5.05M4.75M4.55M3.84M
SG&A % of Revenue27.01%26.88%30.78%35.13%39.98%36.25%49.25%116.35%1854.08%-----18770.8%67889.31%23770.27%62216.91%8073.29%10073.02%
Research & Development6.68M7.21M8.6M5.1M2.44M3.19M1.73M727.12K650.99K837.45K2.29M2.66M4.79M3.41M2.84M2.34M3.21M2.29M3.24M4.74M
R&D % of Revenue6.56%5.66%6.69%4.89%6.15%8.17%5.53%6.35%80.76%-----9572.49%34315.21%15101.26%29957.92%5736.51%12448.09%
Other Operating Expenses00000000000000000000
Operating Income42.91M63.66M59.13M51.35M19.54M20.13M12.94M-3.29M-15.3M-16.7M-15.67M-10.47M-11.8M-11.02M-8.39M-6.96M-8.24M-7.03M-7.78M-8.56M
Operating Margin %42.1%49.96%45.97%49.24%49.18%51.5%41.45%-28.69%-1898.09%------28244.66%-102126.07%-38773.09%-92094.83%-13794.92%-22487.18%
Operating Income Growth %119.56%216.31%357.07%1661.93%227.73%220.48%182.56%68.59%-29.62%-51.62%-86.77%-50.35%-43.25%-56.66%-7.83%18.72%-40.09%2.47%-27.86%-29.7%
EBITDA53.21M74.2M69.56M55.14M19.71M20.29M13.07M-3.21M-15.22M-16.68M-15.65M-10.45M-11.79M-10.97M-8.37M-6.94M-8.19M-6.98M-7.76M-8.55M
EBITDA Margin %52.2%58.23%54.08%52.88%49.59%51.91%41.88%-28.02%-1888.55%------28168.85%-101813.86%-38530.34%-91432.05%-13759.37%-22436.65%
EBITDA Growth %170.01%265.76%432.22%1817.68%229.44%221.61%183.51%69.28%-29.16%-52.1%-87.05%-50.55%-43.94%-57.09%-7.82%18.78%-39.5%2.99%-29.25%-29.61%
D&A (Non-Cash Add-back)10.3M10.54M10.43M3.79M162.94K161.94K133.68K77.41K76.87K21.83K18.67K17.79K17.43K49.45K22.52K21.28K51.59K50.61K20.05K19.25K
EBIT47.09M55.65M58.26M53.52M20.36M20.65M13.47M-2.77M-14.14M-15.85M-14.75M-9.73M-11.27M-10.56M-8.2M-6.84M-8.19M-7.03M-7.79M-8.56M
Net Interest Income00-927.1K612.03K822.28K556.79K500.38K543.85K650.81K847.35K913.49K752.13K544.33K437.61K174.73K84.64K31.76K8.37K-1.01K-2.36K
Interest Income00889.98K1.56M828.95K566.8K510.38K553.86K657.37K857.19K920.04K765.24K550.18K446.38K183.51K93.42K35.34K13.75K4.37K3.02K
Interest Expense001.82M948.24K6.67K10.01K10.01K10.01K6.56K9.84K6.56K13.11K5.85K8.78K8.78K8.78K3.58K5.38K5.38K5.38K
Other Income/Expense-4.18M-8.01M-2.68M1.23M805.98K518.62K528.4K510.52K1.15M843.34K914.72K722.93K530.96K449.95K180.28K108.21K49.99K-1.83K-11.07K-4.45K
Pretax Income38.73M55.65M56.45M52.58M20.35M20.64M13.46M-2.78M-14.15M-15.86M-14.75M-9.74M-11.27M-10.57M-8.21M-6.85M-8.19M-7.03M-7.79M-8.57M
Pretax Margin %38%43.67%43.89%50.42%51.21%52.82%43.14%-24.24%-1755.51%------27637.7%-100538.67%-38537.88%-92118.83%-13814.54%-22498.86%
Income Tax12.74M17.04M42.43M-55.99M521.51K0000-1.39M000000-585.62K000
Effective Tax Rate %32.9%30.63%75.16%-106.49%2.56%0%0%0%0%8.79%0%0%0%0%0%0%7.15%0%0%0%
Net Income25.99M38.6M14.02M108.56M19.83M20.64M13.46M-2.78M-14.15M-14.47M-14.75M-9.74M-11.27M-10.57M-8.21M-6.85M-7.6M-7.04M-7.79M-8.57M
Net Margin %25.5%30.29%10.9%104.11%49.9%52.82%43.14%-24.24%-1755.51%------27637.7%-100538.67%-35782.43%-92142.84%-13814.54%-22498.86%
Net Income Growth %31.07%86.98%4.13%4009.63%240.11%242.71%191.26%71.5%-25.53%-36.9%-79.73%-42.18%-48.24%-50.19%-5.36%20.02%-64.15%2.51%-27.99%-29.82%
Net Income (Continuing)25.99M38.6M14.02M108.56M19.83M20.64M13.46M-2.78M-14.15M-14.47M-14.75M-9.74M-11.27M-10.57M-8.21M-6.85M-7.6M-7.03M-7.79M-8.57M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.290.430.151.260.280.300.22-0.05-0.25-0.25-0.26-0.17-0.259.77-0.19-0.16-0.19-0.18-0.20-0.22
EPS Growth %3.57%43.33%-31.82%2769.49%212%220%184.62%72.24%0%-102.56%-36.84%-6.25%-31.58%5527.78%5%27.27%-58.33%10%-5.26%0%
EPS (Basic)0.330.480.181.420.290.320.22-0.05-0.25-0.25-0.26-0.17-0.259.78-0.19-0.17-0.19-0.18-0.21-0.22
Diluted Shares Outstanding92.48M92.98M93.92M86.21M71.92M68.98M61.51M58.83M57.62M57.5M57.39M56.55M45.37M44.09M41.86M41.18M39.76M38.25M38.11M38.11M
Basic Shares Outstanding78.44M79.51M78.84M75.93M67.93M65.24M61.51M58.83M57.62M57.5M57.39M56.55M45.37M44.03M41.18M40.32M39.76M38.25M37.16M38.11M
Dividend Payout Ratio--------------------